ANAB Nasdaq· AnaptysBio Inc.
FundamentalsNews digest Peer analysis
ANAB Nasdaq· AnaptysBio Inc.
Earnings report Q3 2023

ANAB Reports Strong Revenue Growth in Latest Quarter

Segments of revenue

ANAB reported collaboration revenue of $3.32 million for the three months ended September 30, 2023, compared to $1.29 million in the same period last year. For the nine months ended September 30, 2023, collaboration revenue amounted to $8.15 million, up from $3.48 million in the prior year.


ANAB demonstrated robust revenue growth in the latest quarter, with collaboration revenue increasing by 156% compared to the same period last year. This growth can be attributed to the company's successful partnerships and collaborations, which have resulted in increased revenue streams. ANAB's management highlighted the positive impact of these collaborations on the company's financial performance.


Despite the strong revenue growth, ANAB reported a net loss of $37.31 million for the quarter, compared to a net loss of $33.50 million in the prior year. This indicates that the company's operating expenses exceeded its revenue, resulting in a negative bottom line. ANAB's management should focus on optimizing its cost structure and improving operational efficiency to address this challenge.


ANAB's collaboration revenue growth outpaced its operating expenses, indicating that the company's revenue generation efforts are gaining traction. Additionally, ANAB reported an unrealized gain of $1.26 million on available-for-sale securities, which contributed to its comprehensive loss.


ANAB delivered strong revenue growth in the latest quarter, driven by increased collaboration revenue. However, the company continues to face challenges in achieving profitability, as evidenced by its net loss. ANAB's management should prioritize cost management and operational efficiency to improve its financial performance and work towards sustainable profitability. Overall, ANAB's revenue growth highlights its ability to leverage partnerships and collaborations effectively, positioning the company for future success.

Source documents

Form 10-Q  filed on Nov 02, 2023
31 pages scanned

Reference data

Company financials Q3 revenue 9M
Analyst estimates Q3 EPS missed by -15.91%
Sign up to Fey

Get in-depth analysis on thousands of stocks for just $30/month. Cancel anytime.